G. Richard Granneman
- Infectious Diseases top 0.5%
- Virology top 0.5%
- Pharmacology top 0.2%
- Pediatrics, Perinatology and Child Health top 1%
- Oncology top 5%
- Co-authors
- Richard BertzAnn HsuJohn M. LeonardEllis V. BrownJohn H. CavanaughDale J. KempfEugene SunAkhteruzzaman Molla
- Topics
- Antibiotics Pharmacokinetics and Efficacy (31 papers)Drug Transport and Resistance Mechanisms (22 papers)Pharmacogenetics and Drug Metabolism (20 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
G. Richard Granneman
94 papers receiving 4.6k citations
Hit Papers
Peers
Comparison fields: 5 of 135
- Infectious Diseases 1.9k
- Virology 1.3k
- Pharmacology 989
- Pediatrics, Perinatology and Child Health 894
- Oncology 749
Countries citing papers authored by G. Richard Granneman
This map shows the geographic impact of G. Richard Granneman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Richard Granneman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Richard Granneman more than expected).
Fields of papers citing papers by G. Richard Granneman
This network shows the impact of papers produced by G. Richard Granneman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Richard Granneman. The network helps show where G. Richard Granneman may publish in the future.
Co-authorship network of co-authors of G. Richard Granneman
This figure shows the co-authorship network connecting the top 25 collaborators of G. Richard Granneman. A scholar is included among the top collaborators of G. Richard Granneman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Richard Granneman. G. Richard Granneman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 21 | |
| 2 | Assessment of the pharmacokinetic interaction between ABT-378/ritonavir and efavirenz in healthy volunteers and in HIV + subjects | 1 |
| 3 | 133 | |
| 4 | 14 | |
| 5 | 16 | |
| 6 | 64 | |
| 7 | 27 | |
| 8 | 29 | |
| 9 | Ordered accumulation of mutations in HIV protease confers resistance to ritonavirbreakdown → | 601 |
| 10 | 24 | |
| 11 | 5 | |
| 12 | 31 | |
| 13 | 10 | |
| 14 | 24 | |
| 15 | 5 | |
| 16 | 8 | |
| 17 | 12 | |
| 18 | 6 | |
| 19 | 36 | |
| 20 | 9 |
About G. Richard Granneman
G. Richard Granneman is a scholar working on Pharmacology, Virology and Pharmacology, having authored 95 papers that have together received 4.9k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (31 papers), Drug Transport and Resistance Mechanisms (22 papers) and Pharmacogenetics and Drug Metabolism (20 papers). The work is most often cited by research in Virology (1.3k citations), Pharmacology (989 citations) and Infectious Diseases (1.9k citations). G. Richard Granneman has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Richard Bertz, Ann Hsu, John M. Leonard, Ellis V. Brown, John H. Cavanaugh, Dale J. Kempf, Eugene Sun, Akhteruzzaman Molla, Lawrence T. Sennello and Guoliang Cao. Their work appears in journals such as Journal of the American Chemical Society, Nature Medicine and Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.